0001193125-20-193282.txt : 20200814 0001193125-20-193282.hdr.sgml : 20200814 20200715151702 ACCESSION NUMBER: 0001193125-20-193282 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20200715 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BIOSPECIFICS TECHNOLOGIES CORP CENTRAL INDEX KEY: 0000875622 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 113054851 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 35 WILBUR ST CITY: LYNBROOK STATE: NY ZIP: 11563 BUSINESS PHONE: 302-842-8450 MAIL ADDRESS: STREET 1: 2 RIGHTER PARKWAY, SUITE 200 CITY: WILMINGTON STATE: DE ZIP: 19803 CORRESP 1 filename1.htm CORRESP

BioSpecifics Technologies Corp.

2 Righter Parkway, Suite 200

Wilmington, DE 19803

July 15, 2020

VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attention:      Ada Sarmento

 

  Re:

BioSpecifics Technologies Corp.

Registration Statement on Form S-3

Filed June 26, 2020

File No. 333-239484

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, BioSpecifics Technologies Corp. hereby requests acceleration of the effective date of the above referenced registration statement, as amended, so that such registration statement may become effective at 4:30 p.m. (Washington, D.C. time) on July 17, 2020, or as soon as practicable thereafter.

 

BIOSPECIFICS TECHNOLOGIES CORP.

By:

  

/s/ Joseph Truitt

 

Name:

  

Joseph Truitt

 

Title:

  

Chief Executive Officer